Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-26-265834
Filing Date
2026-06-10
Accepted
2026-06-10 16:10:22
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d159800ddefa14a.htm DEFA14A 40664
2 GRAPHIC g159800dsp006.jpg GRAPHIC 136143
3 GRAPHIC g159800dsp007.jpg GRAPHIC 137851
  Complete submission text file 0001193125-26-265834.txt   419466
Mailing Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265
Business Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265 336-841-0300
vTv Therapeutics Inc. (Filer) CIK: 0001641489 (see all company filings)

EIN.: 473916571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37524 | Film No.: 261079757
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)